Clinical Trial Update: A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating piclidenoson for moderate-to-severe plaque psoriasis focusing on safety and efficacy; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Piclidenoson (Piclidenoson)

Snippet

Sponsor: Can-Fite BioPharma | Conditions: Plaque Psoriasis | Phase 3 | Status: NOT_YET_RECRUITING